RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Monroe, NC · +51 more sites
Alzheimer's Disease clinical trials in Monroe, NC
1 recruiting alzheimer's disease studies with a site in Monroe, NC.
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.